GnuBio
Bio-Rad Shutters Former GnuBio Facility as Part of Digital Biology R&D Consolidation
The company acquired GnuBio, which was developing a droplet-based sequencing platform, in 2014 for $39.7 million in cash and $10 million in contingent payments.
Bio-Rad Q3 Revenues Jump 6 Percent
NEW YORK (GenomeWeb) — Bio-Rad reported after the close of the market on Tuesday a 5 percent increase in third quarter revenues including a 6 percent spike in sales for its Life Science segment.
Bio-Rad Aims to Launch GnuBio Sequencer within Two Years, Discloses Purchase Price of up to $110M
Premium
This article was originally published May 12.
Life Science Sales Boost Bio-Rad Q1 Revenues; Firm Details Droplet-based Sequencing Tech Investment
Premium
NEW YORK (GenomeWeb) — Bio-Rad this week reported a net sales increase of 3 percent in its Life Science segment in the first quarter versus the same period last year.
Bio-Rad Q1 Revenues Up 2 Percent; Will Pay Up to $110M for GnuBio
NEW YORK (GenomeWeb) — Bio-Rad said after the close of the market on Tuesday that its first quarter revenues increased 2 percent as its Life Science sales spiked 3 percent year over year.
Oct 23, 2012
Oct 4, 2012
GnuBio Raises $10M in Private Financing
Sep 11, 2012
Apr 24, 2012
Oct 4, 2011
Jul 19, 2011